A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 14,951 shares of ABCL stock, worth $41,264. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,951
Previous 13,927 7.35%
Holding current value
$41,264
Previous $41,000 7.32%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.39 - $3.49 $2,447 - $3,573
1,024 Added 7.35%
14,951 $38,000
Q2 2024

Aug 12, 2024

BUY
$2.73 - $4.73 $1,695 - $2,937
621 Added 4.67%
13,927 $41,000
Q1 2024

May 09, 2024

SELL
$4.29 - $5.97 $4,088 - $5,689
-953 Reduced 6.68%
13,306 $60,000
Q4 2023

Feb 07, 2024

BUY
$3.91 - $5.93 $55,752 - $84,555
14,259 New
14,259 $81,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $787M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.